Diagnostic Utility of CXCL13 in Lyme Neuroborreliosis

Clin Infect Dis. 2021 May 18;72(10):1727-1729. doi: 10.1093/cid/ciaa337.

Authors

Franc Strle¹, Anna J Henningsson², Klemen Strle³

Affiliations

¹ Department of Infectious Diseases, University Medical Center Ljubljana, Ljubljana, Slovenia.
² Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
³ Division of Infectious Diseases, Wadsworth Center, New York Department of Health, Albany, New York, USA.

PMID: 32221531
DOI: 10.1093/cid/ciaa337

No abstract available

Keywords: CXCL13; Lyme disease; diagnosis; immune mediators; neuroborreliosis.

Publication types

Editorial
Comment

MeSH terms

Chemokine CXCL13
Humans
Immunologic Tests
Lyme Neuroborreliosis* / diagnosis

Substances

CXCL13 protein, human
Chemokine CXCL13